Resources Contact Us Home
Binding peptides for carcinoembryonic antigen (CEA)

Image Number 5 for United States Patent #7438890.

The present invention provides binding moieties for CEA, which have a variety of uses wherever detecting, isolating or localizing CEA, and particularly CEA as opposed to cross-reactive antigens such as NCA, is advantageous. Particularly disclosed are synthetic, isolated polypeptides capable of binding CEA, which is overexpressed in adenocarcinomas of endodermally derived digestive system epithelia and fetal colon. Such polypeptides and disclosed derivatives are useful, e.g., as imaging agents for CEA-expressing tumors.

  Recently Added Patents
Process for filtering interferograms obtained from SAR images acquired on the same area
Barrier layers comprising Ni-inclusive ternary alloys, coated articles including barrier layers, and methods of making the same
Remote management of networked systems using secure modular platform
Ultrathin fluid-absorbent cores
Method and apparatus for exercise monitoring combining exercise monitoring and visual data with wireless internet connectivity
  Randomly Featured Patents
Torque converter with a thin torus turbine
Cyclic hydraulic actuator
Picture quality adjusting device and a television set having a picture quality adjusting device
Pedestal for fiber optic cable
Methods of protection against emesis in mammals by administration of a 3-alkoxy-thianaphthene-2-carboxamide
System and method for reducing thermal shock in a hydrogen diffusion cell
Architecture for signal and power distribution in wireless data network
Gearbox comprising a stationary gear component formed on the basis of variable flank profiles of gear teeth
Device for removing objects from enclosed areas
Benzenesulfonyl ureas and process for their manufacture